Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Titel:
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Auteur:
Orkin, Chloe DeJesus, Edwin Ramgopal, Moti Crofoot, Gordon Ruane, Peter LaMarca, Anthony Mills, Anthony Vandercam, Bernard de Wet, Joseph Rockstroh, Jürgen Lazzarin, Adriano Rijnders, Bart Podzamczer, Daniel Thalme, Anders Stoeckle, Marcel Porter, Danielle Liu, Hui C Cheng, Andrew Quirk, Erin SenGupta, Devi Cao, Huyen